Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Symbion Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (238)
ARTG (46)
Cancellation for failure to pay annual charge (4)
Cancellation or suspension (2)
Listed medicine compliance report (1)

Date

2024 (15)
2023 (13)
2022 (8)
2021 (7)
2020 (7)
2019 (46)
2018 (115)
2017 (53)
2015 (6)
2014 (7)
2013 (2)
2012 (8)
2011 (3)
2003 (1)

Results for "[search-keyword]"

Search

Sponsor content

291 result(s) found, displaying 51 to 60

PHARMACY CHOICE ACID & HEARTBURN RELIEF EXTRA STRENGTH ranitidine (as hydrochloride) 300 mg tablet blister pack (Extension of suspension from the ARTG under s.29E(3))

28 January 2020

Cancellation or suspension

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
PHARMACY CHOICE DICLOFENAC 25 diclofenac sodium 25 mg enteric coated tablets blister pack (297082)

1 December 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHARMACY CHOICE DICLOFENAC 25 diclofenac sodium 25 mg enteric coated tablets blister pack.
PHARMACY CHOICE IBUPROFEN PAIN RELIEF 200mg tablet - film coated blister pack Cancelled under Section 30(1)(c) of the Act

5 December 2019

Cancellation by sponsor

Requested by Symbion Pty Ltd
PHARMACY CHOICE EC ASPIRIN 100 aspirin 100mg enteric coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

5 December 2019

Cancellation by sponsor

Requested by Symbion Pty Ltd
Pharmacy Choice Worming Tablets Cancelled under Section 30(1)(c) of the Act

5 December 2019

Cancellation by sponsor

Requested by Symbion Pty Ltd
Faulding ImmuneBiotic Liquid Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Symbion Pty Ltd
Faulding ImmuneBiotic Capsules Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Symbion Pty Ltd
Faulding Kids Immune Booster Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Symbion Pty Ltd
Faulding Probiotic Immune Guard Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Symbion Pty Ltd
Faulding Kids Immune booster chewable tablets Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Symbion Pty Ltd

Pages

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.